JP2024535880A5 - - Google Patents
Info
- Publication number
- JP2024535880A5 JP2024535880A5 JP2024517408A JP2024517408A JP2024535880A5 JP 2024535880 A5 JP2024535880 A5 JP 2024535880A5 JP 2024517408 A JP2024517408 A JP 2024517408A JP 2024517408 A JP2024517408 A JP 2024517408A JP 2024535880 A5 JP2024535880 A5 JP 2024535880A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- pharmaceutical product
- product according
- agent
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163246755P | 2021-09-21 | 2021-09-21 | |
| US63/246,755 | 2021-09-21 | ||
| PCT/US2022/044003 WO2023049075A1 (en) | 2021-09-21 | 2022-09-19 | Ibudilast in combination therapy for use in the treatment of glioblastoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535880A JP2024535880A (ja) | 2024-10-02 |
| JP2024535880A5 true JP2024535880A5 (https=) | 2025-09-25 |
Family
ID=83688651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517408A Pending JP2024535880A (ja) | 2021-09-21 | 2022-09-19 | 膠芽腫の治療における使用のための併用療法におけるイブジラスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230090534A1 (https=) |
| EP (1) | EP4404928A1 (https=) |
| JP (1) | JP2024535880A (https=) |
| CN (1) | CN118139619A (https=) |
| CA (1) | CA3231869A1 (https=) |
| WO (1) | WO2023049075A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12005049B2 (en) | 2021-07-26 | 2024-06-11 | Medicinova, Inc. | Methods of preventing cancer metastasis |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395747B1 (en) | 1998-08-10 | 2002-05-28 | Sauro Sakoda | Remedies for multiple sclerosis |
| JP4954085B2 (ja) | 2004-12-06 | 2012-06-13 | メディシノバ， インコーポレイテッド | 神経障害性疼痛及びその関連する症状を治療するためのイブジラスト |
| US8138201B2 (en) | 2007-07-11 | 2012-03-20 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| AU2014319921A1 (en) * | 2013-09-11 | 2016-03-17 | Compugen Ltd. | Anti-VSTM5 antibodies and the use thereof in therapy and diagnosis |
| WO2018119262A1 (en) * | 2016-12-22 | 2018-06-28 | Medicinova, Inc. | Methods of treating glioblastoma multiforme using ibudilast |
| CN110914302A (zh) * | 2017-06-01 | 2020-03-24 | 赛托姆克斯治疗学股份有限公司 | 可活化抗pdl1抗体及其使用方法 |
| JP2021512921A (ja) * | 2018-02-12 | 2021-05-20 | メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
| WO2020028134A1 (en) * | 2018-07-30 | 2020-02-06 | Fred Hutchinson Cancer Research Center | Methods and compositions for treating cancer |
-
2022
- 2022-09-19 CA CA3231869A patent/CA3231869A1/en active Pending
- 2022-09-19 JP JP2024517408A patent/JP2024535880A/ja active Pending
- 2022-09-19 WO PCT/US2022/044003 patent/WO2023049075A1/en not_active Ceased
- 2022-09-19 EP EP22786655.5A patent/EP4404928A1/en active Pending
- 2022-09-19 CN CN202280068158.5A patent/CN118139619A/zh active Pending
- 2022-09-19 US US17/947,560 patent/US20230090534A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chiang et al. | Recurrent aphthous stomatitis–Etiology, serum autoantibodies, anemia, hematinic deficiencies, and management | |
| US11826317B2 (en) | Combination therapy with notch and PD-1 or PD-L1 inhibitors | |
| Ruocco et al. | Pemphigus: associations and management guidelines: facts and controversies | |
| Piscitelli et al. | Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers | |
| KR20240056564A (ko) | T 세포 림프종을 치료하기 위한 약물을 제조하는 데 있어서 ezh2 억제제의 용도 | |
| HRP20100014T1 (hr) | Uporaba il-23 i il-17 antagonista u liječenju autoimune očne upalne bolesti | |
| JP2019526595A5 (https=) | ||
| JP2024535880A5 (https=) | ||
| JP2020500152A5 (https=) | ||
| FI3519049T3 (fi) | Turvallinen ja tehokas menetelmä psoriaasin hoitamiseen il23- spesifisellä vasta-aineella | |
| EP2582373A1 (en) | Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation | |
| TW202214242A (zh) | 西奧羅尼或其衍生物在製備用於預防和/或治療非霍奇金淋巴瘤的藥物之用途 | |
| JP2020502261A5 (https=) | ||
| JP2022523045A5 (https=) | ||
| JP2024016209A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| Luqmani | Discontinuation of therapies in vasculitis | |
| JP2024512558A5 (https=) | ||
| He et al. | Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis | |
| US20140127295A1 (en) | Compositions, process of preparation of said compositions and method of treating inflammatory diseases | |
| WO2021023291A1 (zh) | 原黄素在肺癌治疗中的应用 | |
| Mortazavi et al. | Oral fixed drug eruption: Analyses of reported cases in the literature | |
| TW202308641A (zh) | 用於治療癌症之方法及包含cdk抑制劑之給藥方案 | |
| CN112843146A (zh) | 中成药三黄膏的新用途 | |
| CN106902119B (zh) | 枸橼酸托法替布在治疗多发性大动脉炎药物中的应用 |